In HT-29 colorectal cell lines, EGCG upregulated the activity of TfR (Transferrin receptor), which is a carrier protein for transferrin, and inhibited the activity of the Ferritin-H protein via the iron chelation activity in HT-29 colorectal cancer cells [121]. Here, TFRC is linked to colorectal cancer.